Literature DB >> 27336033

Anhedonia in the psychosis risk syndrome: associations with social impairment and basal orbitofrontal cortical activity.

Victoria L Cressman1, Scott A Schobel1, Sara Steinfeld2, Shelly Ben-David2, Judy L Thompson1, Scott A Small3, Holly Moore4, Cheryl M Corcoran4.   

Abstract

BACKGROUND/
OBJECTIVES: Anhedonia is associated with poor social function in schizophrenia. Here, we examined this association in individuals at clinical high risk (CHR) for schizophrenia and related psychotic disorders, taking into account social anxiety. We then explored correlations between anhedonia and basal metabolic activity in selected forebrain regions implicated in reward processing.
METHODS: In 62 CHR individuals and 37 healthy controls, we measured social adjustment (Social Adjustment Self-Report Scale), social and physical anhedonia (Chapman Revised Anhedonia Scales), and social anxiety (Social Anxiety Scale for Adolescents) in cross-section. In a subgroup of 25 CHR individuals for whom high-spatial-resolution basal-state functional magnetic resonance imaging data were available, we also assessed correlations of these socio-affective constructs with basal cerebral blood volume in orbitofrontal cortex and related regions involved in reward processing.
RESULTS: Relative to controls, CHR individuals reported social impairment, greater social and physical anhedonia, and more social anxiety, exhibiting impairments comparable to schizophrenia. Regression analyses showed that anhedonia predicted social impairment and correlated negatively with basal cerebral blood volume within the orbitofrontal cortex (all P's<0.05).
CONCLUSIONS: Anhedonia and social anxiety are prominent in CHR individuals. Trait-like anhedonia may be a core phenotype related to orbitofrontal cortical function that, independent of symptoms, predicts social impairment. These data provide a rationale for interventions that target anhedonia and related activity in orbitofrontal cortical circuits in CHR individuals.

Entities:  

Year:  2015        PMID: 27336033      PMCID: PMC4849450          DOI: 10.1038/npjschz.2015.20

Source DB:  PubMed          Journal:  NPJ Schizophr        ISSN: 2334-265X


  61 in total

1.  Extended amygdala and emotional salience: a PET activation study of positive and negative affect.

Authors:  Israel Liberzon; K Luan Phan; Laura R Decker; Stephan F Taylor
Journal:  Neuropsychopharmacology       Date:  2002-11-15       Impact factor: 7.853

2.  Factorial structure of the Scale of Prodromal Symptoms.

Authors:  K A Hawkins; T H McGlashan; D Quinlan; T J Miller; D O Perkins; R B Zipursky; J Addington; S W Woods
Journal:  Schizophr Res       Date:  2004-06-01       Impact factor: 4.939

Review 3.  The limbic lobe and its output channels: implications for emotional functions and adaptive behavior.

Authors:  Lennart Heimer; Gary W Van Hoesen
Journal:  Neurosci Biobehav Rev       Date:  2005-09-23       Impact factor: 8.989

Review 4.  Motivating forces of human actions. Neuroimaging reward and social interaction.

Authors:  Henrik Walter; Birgit Abler; Angela Ciaramidaro; Susanne Erk
Journal:  Brain Res Bull       Date:  2005-07-25       Impact factor: 4.077

Review 5.  Affective traits in schizophrenia and schizotypy.

Authors:  William P Horan; Jack J Blanchard; Lee Anna Clark; Michael F Green
Journal:  Schizophr Bull       Date:  2008-07-29       Impact factor: 9.306

6.  Psychometric evaluation of the Social Anxiety Scale for Adolescents and the Social Phobia and Anxiety Inventory for Children: construct validity and normative data.

Authors:  Eric A Storch; Carrie Masia-Warner; Heather C Dent; Jonathan W Roberti; Paige H Fisher
Journal:  J Anxiety Disord       Date:  2004

7.  The Nithsdale schizophrenia survey. IV. Social adjustment by self-report.

Authors:  R G McCreadie; E T Barron
Journal:  Br J Psychiatry       Date:  1984-05       Impact factor: 9.319

8.  Social anhedonia and schizotypy in a community sample: the Maryland longitudinal study of schizotypy.

Authors:  Jack J Blanchard; Lindsay M Collins; Minu Aghevli; Winnie W Leung; Alex S Cohen
Journal:  Schizophr Bull       Date:  2009-10-22       Impact factor: 9.306

9.  Negative symptoms of schizophrenia are associated with abnormal effort-cost computations.

Authors:  James M Gold; Gregory P Strauss; James A Waltz; Benjamin M Robinson; Jamie K Brown; Michael J Frank
Journal:  Biol Psychiatry       Date:  2013-02-07       Impact factor: 13.382

10.  Social anxiety among adolescents: linkages with peer relations and friendships.

Authors:  A M La Greca; N Lopez
Journal:  J Abnorm Child Psychol       Date:  1998-04
View more
  13 in total

1.  Social reward processing: A biomarker for predicting psychosis risk?

Authors:  Andrea Pelletier-Baldelli; Joseph M Orr; Jessica A Bernard; Vijay A Mittal
Journal:  Schizophr Res       Date:  2018-08-07       Impact factor: 4.939

2.  Acute effects of smoked marijuana in marijuana smokers at clinical high-risk for psychosis: A preliminary study.

Authors:  Nehal P Vadhan; Cheryl M Corcoran; Gill Bedi; John G Keilp; Margaret Haney
Journal:  Psychiatry Res       Date:  2017-08-01       Impact factor: 3.222

3.  Expanding the positivity offset theory of anhedonia to the psychosis continuum.

Authors:  Marcel Riehle; Matthias Pillny; Tania M Lincoln
Journal:  Schizophrenia (Heidelb)       Date:  2022-05-03

Review 4.  Anhedonia in Depression and Schizophrenia: Brain Reward and Aversion Circuits.

Authors:  Sugai Liang; Yue Wu; Li Hanxiaoran; Andrew J Greenshaw; Tao Li
Journal:  Neuropsychiatr Dis Treat       Date:  2022-07-07       Impact factor: 2.989

5.  Pupillometer-based neurofeedback cognitive training to improve processing speed and social functioning in individuals at clinical high risk for psychosis.

Authors:  Jimmy Choi; Cheryl M Corcoran; Joanna M Fiszdon; Michael Stevens; Daniel C Javitt; Melissa Deasy; Lawrence C Haber; Michael J Dewberry; Godfrey D Pearlson
Journal:  Psychiatr Rehabil J       Date:  2016-08-25

6.  Olfactory deficits in individuals at risk for psychosis and patients with schizophrenia: relationship with socio-cognitive functions and symptom severity.

Authors:  Tsutomu Takahashi; Mihoko Nakamura; Daiki Sasabayashi; Yuko Komori; Yuko Higuchi; Yumiko Nishikawa; Shimako Nishiyama; Hiroko Itoh; Yuri Masaoka; Michio Suzuki
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-10-25       Impact factor: 5.270

7.  Perceived stress influences anhedonia and social functioning in a community sample enriched for psychosis-risk.

Authors:  Andrea Pelletier-Baldelli; Gregory P Strauss; Franchesca S Kuhney; Charlotte Chun; Tina Gupta; Lauren M Ellman; Jason Schiffman; Vijay A Mittal
Journal:  J Psychiatr Res       Date:  2021-01-11       Impact factor: 4.791

8.  Diminished reward responsiveness is associated with lower reward network GluCEST: an ultra-high field glutamate imaging study.

Authors:  Valerie J Sydnor; Bart Larsen; Christian Kohler; Andrew J D Crow; Sage L Rush; Monica E Calkins; Ruben C Gur; Raquel E Gur; Kosha Ruparel; Joseph W Kable; Jami F Young; Sanjeev Chawla; Mark A Elliott; Russell T Shinohara; Ravi Prakash Reddy Nanga; Ravinder Reddy; Daniel H Wolf; Theodore D Satterthwaite; David R Roalf
Journal:  Mol Psychiatry       Date:  2021-01-21       Impact factor: 13.437

9.  Relations Among Anhedonia, Reinforcement Learning, and Global Functioning in Help-seeking Youth.

Authors:  LeeAnn Akouri-Shan; Jason Schiffman; Zachary B Millman; Caroline Demro; John Fitzgerald; Pamela J Rakhshan Rouhakhtar; Samantha Redman; Gloria M Reeves; Shuo Chen; James M Gold; Elizabeth A Martin; Cheryl Corcoran; Jonathan P Roiser; Robert W Buchanan; Laura M Rowland; James A Waltz
Journal:  Schizophr Bull       Date:  2021-10-21       Impact factor: 7.348

10.  Functional Connectivity Anomalies in Adolescents with Psychotic Symptoms.

Authors:  Francesco Amico; Erik O'Hanlon; Dominik Kraft; Viola Oertel-Knöchel; Mary Clarke; Ian Kelleher; Niamh Higgins; Helen Coughlan; Daniel Creegan; Mark Heneghan; Emmet Power; Lucy Power; Jessica Ryan; Thomas Frodl; Mary Cannon
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.